• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗无接触隐静脉移植物的生活质量明显优于传统静脉移植物。

Quality of Life After Percutaneous Coronary Intervention in No-Touch Saphenous Vein Grafts is Significantly Better Than in Conventional Vein Grafts.

机构信息

Department of Cardiothoracic and Vascular Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

University Health Care Research Centre, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

出版信息

Braz J Cardiovasc Surg. 2022 Aug 16;37(4):430-438. doi: 10.21470/1678-9741-2021-0576.

DOI:10.21470/1678-9741-2021-0576
PMID:35976202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9423813/
Abstract

OBJECTIVE

To compare health-related quality of life (HRQoL) of patients primarily treated with a no-touch saphenous vein graft with that of patients who received a conventional graft.

METHODS

The study included all individuals treated with a percutaneous coronary intervention (PCI) on a saphenous vein graft (SVG) between January 2006 and June 2020. The RAND-36 health survey was used to assess HRQoL. The Mann-Whitney U test was used to test differences in HRQoL between the two groups. Effect size was estimated via Cohen's d. The average treatment effect between the groups was tested by propensity score matching (PSM).

RESULTS

Of the 346 patients treated with a PCI in a stenosed or occluded SVG, 165 responded to RAND-36 (no-touch: n=48; conventional: n=117). Patients with a no-touch graft reported better mean values on seven of the eight health survey domains. Statistically significant differences were observed for four of the domains, all in favour of the no-touch group. The effect size estimates indicated a small difference for five domains, with the highest values (>0.40) seen for the general health and energy/fatigue domains. PSM confirmed a statistically significant difference for the physical functioning and general health domains.

CONCLUSION

At a mean follow-up of 5.4 years, patients who received a PCI in no-touch vein grafts showed significantly better HRQoL than those who received a PCI in conventional vein grafts.

摘要

目的

比较主要接受无接触隐静脉移植物治疗的患者与接受常规移植物治疗的患者的健康相关生活质量(HRQoL)。

方法

该研究纳入了 2006 年 1 月至 2020 年 6 月期间所有接受经皮冠状动脉介入治疗(PCI)的隐静脉移植物(SVG)患者。采用 RAND-36 健康调查评估 HRQoL。采用曼-惠特尼 U 检验比较两组 HRQoL 的差异。采用 Cohen's d 估计效应大小。采用倾向评分匹配(PSM)检验两组间的平均治疗效果。

结果

在 346 例因 SVG 狭窄或闭塞而行 PCI 的患者中,有 165 例对 RAND-36 做出了回应(无接触组:n=48;常规组:n=117)。无接触移植物组的 8 个健康调查领域中有 7 个领域的平均评分较高。四个领域的差异具有统计学意义,均有利于无接触组。效应大小估计值表明,有五个领域存在较小的差异,其中一般健康和精力/疲劳领域的得分最高(>0.40)。PSM 证实了无接触组和常规组在生理功能和一般健康领域的差异具有统计学意义。

结论

在平均随访 5.4 年后,接受无接触静脉移植物 PCI 的患者的 HRQoL 明显优于接受常规静脉移植物 PCI 的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5278/9423813/376848be4a1f/rbccv-37-04-0430-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5278/9423813/d042a00ebea8/rbccv-37-04-0430-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5278/9423813/376848be4a1f/rbccv-37-04-0430-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5278/9423813/d042a00ebea8/rbccv-37-04-0430-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5278/9423813/376848be4a1f/rbccv-37-04-0430-g02.jpg

相似文献

1
Quality of Life After Percutaneous Coronary Intervention in No-Touch Saphenous Vein Grafts is Significantly Better Than in Conventional Vein Grafts.经皮冠状动脉介入治疗无接触隐静脉移植物的生活质量明显优于传统静脉移植物。
Braz J Cardiovasc Surg. 2022 Aug 16;37(4):430-438. doi: 10.21470/1678-9741-2021-0576.
2
Clinical Outcomes After Surgical Revascularization Using No-Touch Versus Conventional Saphenous Vein Grafts: Mid-Term Follow-Up of Propensity Score Matched Cohorts.使用非接触式与传统大隐静脉移植物进行手术血运重建后的临床结果:倾向评分匹配队列的中期随访
Semin Thorac Cardiovasc Surg. 2023 Summer;35(2):228-236. doi: 10.1053/j.semtcvs.2021.12.002. Epub 2021 Dec 5.
3
Antiplatelet drug selection in PCI to vein grafts in patients with acute coronary syndrome and adverse clinical outcomes: Insights from the British Cardiovascular Intervention Society database.急性冠状动脉综合征伴不良临床结局患者经皮冠状动脉介入治疗中静脉桥病变的抗血小板药物选择:来自英国心血管介入学会数据库的分析。
Catheter Cardiovasc Interv. 2018 Oct 1;92(4):659-665. doi: 10.1002/ccd.27493. Epub 2018 Jan 22.
4
Recanalization of Chronic Total Occlusions in Patients With Previous Coronary Bypass Surgery and Consideration of Retrograde Access via Saphenous Vein Grafts.既往接受冠状动脉搭桥手术患者慢性完全闭塞病变的再通及经大隐静脉桥逆行入路的考量
Circ Cardiovasc Interv. 2016 Jul;9(7). doi: 10.1161/CIRCINTERVENTIONS.115.003515.
5
Long-term results of percutaneous coronary intervention in no-touch vein grafts are significantly better than in conventional vein grafts.非接触式静脉移植物经皮冠状动脉介入治疗的长期效果明显优于传统静脉移植物。
Perfusion. 2025 Jan;40(1):211-220. doi: 10.1177/02676591241230012. Epub 2024 Jan 22.
6
A Case of Using No-Touch Saphenous Vein Graft in Redo CABG after Multiple Failed Percutaneous Coronary Interventions.多例经皮冠状动脉介入治疗失败后的再次冠状动脉旁路移植术(CABG)中使用非接触式隐静脉移植物的病例报告。
Braz J Cardiovasc Surg. 2022 Mar 10;37(1):135-138. doi: 10.21470/1678-9741-2021-0203.
7
Percutaneous Coronary Intervention of Saphenous Vein Graft.经皮冠状动脉介入治疗的隐静脉桥。
Circ Cardiovasc Interv. 2017 May;10(5). doi: 10.1161/CIRCINTERVENTIONS.117.004953.
8
One-year outcomes of percutaneous coronary intervention in native coronary arteries versus saphenous vein grafts in patients with prior coronary artery bypass graft surgery.经皮冠状动脉介入治疗在既往冠状动脉旁路移植术患者中的原生冠状动脉与隐静脉桥中的 1 年结果。
Cardiol J. 2022;29(3):396-404. doi: 10.5603/CJ.a2020.0131. Epub 2020 Oct 1.
9
Relationship between plaque composition by virtual histology intravascular ultrasound and clinical outcomes after percutaneous coronary intervention in saphenous vein graft disease patients: study protocol of a prospective cohort study.基于虚拟组织学血管内超声的斑块成分与经皮冠状动脉介入治疗后静脉桥病变患者临床结局的关系:一项前瞻性队列研究的研究方案。
BMC Cardiovasc Disord. 2018 Dec 12;18(1):233. doi: 10.1186/s12872-018-0975-1.
10
Comparison of clinical outcomes in patients presenting with an acute coronary syndrome due to stent thrombosis or saphenous vein graft occlusion and undergoing percutaneous coronary intervention.因支架血栓形成或隐静脉桥闭塞而出现急性冠状动脉综合征并接受经皮冠状动脉介入治疗的患者的临床结局比较。
Cardiovasc Revasc Med. 2015 Dec;16(8):441-6. doi: 10.1016/j.carrev.2015.10.002. Epub 2015 Oct 24.

引用本文的文献

1
Graft patency of no-touch versus conventionally harvested saphenous vein conduits in coronary artery bypass grafting: A frequentist and Bayesian meta-analysis of randomized trials.冠状动脉搭桥术中非接触式与传统获取的大隐静脉移植物的通畅率:随机试验的频率论和贝叶斯荟萃分析
JTCVS Open. 2025 Feb 21;24:185-205. doi: 10.1016/j.xjon.2025.02.007. eCollection 2025 Apr.
2
Investigating the peri-saphenous vein graft fat attenuation index on computed tomography angiography: relationship with progression of venous coronary artery bypass graft disease and temporal trends.研究 CT 血管造影中隐股静脉移植物脂肪衰减指数与静脉冠状动脉旁路移植病变进展的关系及时间趋势。
BMC Cardiovasc Disord. 2024 Oct 26;24(1):597. doi: 10.1186/s12872-024-04257-4.
3

本文引用的文献

1
The "No-touch" Harvesting Technique Revives the Position of the Saphenous Vein as an Important Conduit in CABG Surgery: 30-year Anniversary.“非接触式”采集技术使大隐静脉在冠状动脉旁路移植术(CABG)中作为重要血管 conduit 的地位得以复兴:30 周年纪念 。 (注:这里“conduit”直译为“管道”,结合医学语境可能是指血管通道之类的意思,具体准确含义需结合更详细的医学背景确定,但按要求不添加解释)
Braz J Cardiovasc Surg. 2021 Oct 17;36(5):I-III. doi: 10.21470/1678-9741-2021-0959.
2
Percutaneous coronary intervention in saphenous vein grafts after coronary artery bypass grafting: a systematic review and meta-analysis.经皮冠状动脉介入治疗冠状动脉旁路移植术后的大隐静脉桥:系统评价和荟萃分析。
Scand Cardiovasc J. 2021 Aug;55(4):245-253. doi: 10.1080/14017431.2021.1900598. Epub 2021 Mar 18.
3
Long-term results of percutaneous coronary intervention in no-touch vein grafts are significantly better than in conventional vein grafts.非接触式静脉移植物经皮冠状动脉介入治疗的长期效果明显优于传统静脉移植物。
Perfusion. 2025 Jan;40(1):211-220. doi: 10.1177/02676591241230012. Epub 2024 Jan 22.
4
For patients with prior coronary artery bypass grafting and recurrent myocardial ischemia, percutaneous coronary intervention on bypass graft or native coronary artery?-A 5-year follow-up cohort study.对于既往行冠状动脉旁路移植术和复发性心肌缺血的患者,旁路移植血管或原生冠状动脉的经皮冠状动脉介入治疗如何?一项 5 年随访队列研究。
Clin Cardiol. 2023 Jun;46(6):680-688. doi: 10.1002/clc.24021. Epub 2023 Apr 28.
Twenty-Five Years of No-Touch Saphenous Vein Harvesting for Coronary Artery Bypass Grafting: Structural Observations and Impact on Graft Performance.
用于冠状动脉旁路移植术的无接触大隐静脉采集25年:结构观察及其对移植物性能的影响
Braz J Cardiovasc Surg. 2020 Feb 1;35(1):91-99. doi: 10.21470/1678-9741-2019-0238.
4
Assessment of the Quality of Life in Patients before and after Coronary Artery Bypass Grafting (CABG): A Prospective Study.冠状动脉旁路移植术(CABG)前后患者生活质量评估:一项前瞻性研究。
Int J Environ Res Public Health. 2020 Feb 22;17(4):1417. doi: 10.3390/ijerph17041417.
5
Quality of life 10 years after cardiac surgery in adults: a long-term follow-up study.成人心脏手术后 10 年的生活质量:一项长期随访研究。
Health Qual Life Outcomes. 2019 May 22;17(1):88. doi: 10.1186/s12955-019-1160-7.
6
Diabetics have Inferior Long-Term Survival and Quality of Life after CABG.糖尿病患者冠状动脉旁路移植术后长期生存率及生活质量较差。
Int J Angiol. 2019 Mar;28(1):50-56. doi: 10.1055/s-0038-1676791. Epub 2019 Jan 2.
7
Surgical Aspects of No-Touch Saphenous Vein Graft Harvesting in CABG: Clinical and Angiographic Follow-Up at 3 Months.冠状动脉旁路移植术中非接触式大隐静脉桥血管获取的手术要点:3个月临床及血管造影随访
Braz J Cardiovasc Surg. 2019 Jan-Feb;34(1):98-100. doi: 10.21470/1678-9741-2018-0352.
8
No-touch vein grafts and the destiny of venous revascularization in coronary artery bypass grafting-a 25 anniversary perspective.非接触式静脉移植物与冠状动脉旁路移植术中静脉血管重建的命运——25周年展望
Ann Cardiothorac Surg. 2018 Sep;7(5):681-685. doi: 10.21037/acs.2018.05.15.
9
Long-term health-related quality of life and survival after cardiac surgery: A prospective study.心脏手术后的长期健康相关生活质量和生存:一项前瞻性研究。
J Thorac Cardiovasc Surg. 2018 Dec;156(6):2183-2190.e2. doi: 10.1016/j.jtcvs.2018.05.087. Epub 2018 Jun 7.
10
Quality of life after elective cardiac surgery in elderly patients.老年患者择期心脏手术后的生活质量
Interact Cardiovasc Thorac Surg. 2019 Feb 1;28(2):199-205. doi: 10.1093/icvts/ivy235.